Table 4.
Univariate and multivariate linear and logistic regression analyses of body parameters pre-neoadjuvant treatment in relation to complications and length of stay. To model the relationship between pre-operative patient variables including body composition parameters, with measures of early post-operative outcomes, univariate analyses with clinically relevant parameters were performed. Variables with a value of P < 0.10 in the univariate analyses were included in the subsequent multivariate (logistic regression) analyses
| Factors | CD ≥ 2 | 30-day readmission | LOS | |
|---|---|---|---|---|
|
Univariate analysis (P) |
Univariate analysis (P) |
Univariate analysis (P) |
Multivariate analysis (P) |
|
| Age | 0.987 | 0.404 | 0.148 | |
| Gender (M:F) | 0.287 | 0.263 | 0.107 | |
| Stage | ||||
|
0–I II–III |
0.952 | 0.350 | 0.418 | |
| ASA | ||||
|
I–II III–IV |
0.144 | 0.977 | 0.773 | |
| Neoadjuvant regimen | ||||
| CHT | 0.875 | 0.318 | 0.317 | |
| CHT + CRT | ||||
| Albumin | 0.438 | *0.020 | 0.943 | |
| Hb | 0.712 | 0.682 | 0.645 | |
| SMI | 0.993 | 0.448 | 0.876 | |
| BMI | 0.214 | 0.549 | 0.351 | |
| VFA | 0.052 | 0.456 | *** < 0.0001 | 0.166 |
| SFA | 0.546 | 0.280 | 0.855 | |
| PNF | 0.094 | 0.864 | 0.050 | 0.189 |
| V/S ratio | *0.033 | 0.822 | *** < 0.0001 | **0.005 |
| Sarcopenia | ||||
|
Yes, % (n) No, % (n) |
0.560 | 0.468 | 0.710 | |
| Sarcopenic obesity | ||||
|
Yes, % (n) No, % (n) |
0.966 | > 0.9 | 0.372 | |